KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 107 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $549,691 | +11.8% | 31,646 | -9.4% | 0.00% | 0.0% |
| Q2 2023 | $491,814 | +17.5% | 34,930 | -10.2% | 0.00% | 0.0% |
| Q1 2023 | $418,392 | -29.1% | 38,884 | -1.3% | 0.00% | 0.0% |
| Q4 2022 | $589,927 | +18.2% | 39,381 | +1.4% | 0.00% | 0.0% |
| Q3 2022 | $499,000 | +30.6% | 38,840 | -1.5% | 0.00% | 0.0% |
| Q2 2022 | $382,000 | +11.7% | 39,440 | +14.6% | 0.00% | – |
| Q1 2022 | $342,000 | -20.1% | 34,410 | -5.5% | 0.00% | -100.0% |
| Q4 2021 | $428,000 | +6.2% | 36,395 | +2.8% | 0.00% | 0.0% |
| Q3 2021 | $403,000 | -28.0% | 35,406 | -12.0% | 0.00% | 0.0% |
| Q2 2021 | $560,000 | -24.9% | 40,232 | -0.2% | 0.00% | 0.0% |
| Q1 2021 | $746,000 | +4.3% | 40,310 | -0.4% | 0.00% | 0.0% |
| Q4 2020 | $715,000 | +15.3% | 40,456 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $620,000 | -15.2% | 40,456 | +41.1% | 0.00% | 0.0% |
| Q2 2020 | $731,000 | +118.9% | 28,671 | +33.0% | 0.00% | 0.0% |
| Q1 2020 | $334,000 | +41.5% | 21,558 | +1.2% | 0.00% | – |
| Q4 2019 | $236,000 | +29.0% | 21,310 | -0.8% | 0.00% | – |
| Q3 2019 | $183,000 | -37.1% | 21,481 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $291,000 | -12.3% | 21,481 | +17.0% | 0.00% | 0.0% |
| Q1 2019 | $332,000 | +20.7% | 18,364 | +87.3% | 0.00% | 0.0% |
| Q4 2018 | $275,000 | +10.0% | 9,806 | 0.0% | 0.00% | – |
| Q3 2018 | $250,000 | – | 9,806 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |